About Hypermed
Hypermed is a Healthcare company based in Memphis (United States) founded in 2012. It operates as a portable diagnostic solutions are developed using hyperspectral imaging. Hypermed has raised $5.04 million across 1 funding round. Hypermed offers products and services including HyperViewâ„¢ and OxyVuâ„¢-1. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, In-Vitro Diagnostics and Diversified. Its legal entity is HyperMed Imaging, Inc. Its competitors include GEN inCode, SD Biosensor, SpectraWAVE, Lepu Medical Technology and Spectrum Dynamics and 4 more; 6 of its 9 listed competitors have raised funding.
Company details
Hypermed was founded in 2012 and is based in Memphis, United States. Operations focus on the medical diagnostics sector, where portable devices employing hyperspectral imaging are created to evaluate tissue oxiometry. This technology measures light absorption in hemoglobin to assess oxidative capacity. The flagship product, HyperView, is an FDA-510(k) cleared handheld device used for non-invasive detection of oxygen saturation, oxyhemoglobin, and deoxyhemoglobin levels in circulatory disorders.
- Headquarters Memphis, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website hypermed.com
- Social LinkedIn
- Legal Name Hypermed Imaging, Inc.
- Total Equity Funding$5.04M (USD)
in 1 rounds
- Latest Funding Round$5.04M (USD), Series A
Mar 2018
Products & Services of Hypermed
Hypermed offers a comprehensive portfolio of products and services, including HyperView™ and OxyVu™-1.
Portable system for assessing superficial tissue oxygenation via hyperspectral imaging.
Device for evaluating tissue health through oxyhemoglobin saturation measurements.
Funding Insights of Hypermed
Hypermed has successfully raised a total of $5.04M through 1 strategic funding round. The most recent funding activity was a Series A round of $5.04 million completed in March 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $5.04M
- Total Rounds 1
- Last Round Series A — $5.04M
- First Round $5.04M
(Mar 2018)
All 1 funding rounds of Hypermed with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2018 | $5.04M | Series A | – | – | – |
Timeline of Hypermed
2 dated milestones of Hypermed across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Hypermed is founded.
- Funding First funding round of $5.0M.
Competitors of Hypermed
Hypermed has 9 listed competitors in our database, 6 of them funded. They include GEN inCode, SD Biosensor, SpectraWAVE, Lepu Medical Technology and Spectrum Dynamics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genincode.com | 2018 | Manchester, United Kingdom | $4.48M | 26 | Genetic and clinical data are integrated for precision cardiac medicines. | |
| sdbiosensor.com | 2001 | Suwon-si, South Korea | – | – | Biosensors for point-of-care diagnostics are developed by SD Biosensor. | |
| spectrawave.com | 2012 | Waltham, United States | $79.88M | 36 | Photonic imaging diagnostics for cardiovascular disease treatment are provided. | |
| lepumedical.com | 1999 | Beijing, China | – | – | Interventional cardiology devices are developed and marketed globally. | |
| spectrum-dynamics.com | 2000 | Morges, Switzerland | – | – | Cardiac imaging systems are manufactured using advanced molecular technologies. | |
| proximdx.com | 2010 | Sunnyvale, United States | $22.9M | – | Handheld immunodiagnostic devices for cardiac vascular diseases are developed. | |
| bostonheartdiagnostics.com | 2007 | Framingham, United States | $10.34M | – | Diagnostics for personalized cardiovascular disease management are developed. | |
| prevenciomed.com | 2006 | Kirkland, United States | $5.68M | – | Protein-based diagnostics and prognostics for cardiovascular diseases are developed. | |
| diadexus.com | 1997 | San Francisco, United States | $49.2M | – | Molecular diagnostic tests for cardiovascular disorders are developed and marketed. |
Detailed competitors of Hypermed
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Hypermed
The website of Hypermed (hypermed.com) receives about 1.5K visits a month.
- Monthly visits1.5K
▲ 42% vs previous month
Websites whose visitors overlap most with Hypermed. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
americanada.com | americanada.com | 100% | – | – | – |
| sentrylink.com | 99% | – | #569,256 | View details | |
skipsmasher.com | skipsmasher.com | 99% | – | #1,714,462 | – |
skipsource.com | skipsource.com | 99% | – | – | – |
accurint.com | accurint.com | 99% | – | #141,461 | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 12 similar websites and full traffic analytics for Hypermed
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 12 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
10 companies that operate in the same segment as Hypermed (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
SMT is recognized as a developer of cardiovascular medical devices. | 1998 | Surat, Gujarat, India | – | USD 106.25 M | 1,090 | |
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | – | 255 | |
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 | |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided. | 2006 | San Francisco, California, United States | USD 109.23 M | USD 747.14 M | 2,000 | |
Provider of neuroprotection devices for carotid artery disease | 2007 | Sunnyvale, California, United States | USD 241.8 M | – | – | |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | 2007 | East Peoria, Illinois, United States | USD 154.77 M | – | 104 | |
Access catheters for neurovascular stroke treatment are provided. | 2015 | Campbell, California, United States | USD 596 M | – | – | |
Biosensor patches are developed for monitoring multiple body vitals. | 2011 | Campbell, California, United States | USD 239.95 M | – | 184 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Hypermed
Complete news archive for Hypermed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hypermed
Hypermed was founded in 2012 and raised its 1st funding round 6 years after it was founded.
Hypermed is headquartered in Memphis, United States. It is registered at Memphis, Tennessee, United States.
Hypermed is a funded company, having raised a total of $5.04M across 1 funding round to date. The company's 1st funding round was a Series A of $5.04M, raised on Mar 2018.
Hypermed was founded in 2012 and is based in Memphis, United States. Operations focus on the medical diagnostics sector, where portable devices employing hyperspectral imaging are created to evaluate tissue oxiometry. This technology measures light absorption in hemoglobin to assess oxidative capacity. The flagship product, HyperView, is an FDA-510(k) cleared handheld device used for non-invasive detection of oxygen saturation, oxyhemoglobin, and deoxyhemoglobin levels in circulatory disorders.
Hypermed's top competitors include GEN inCode, SD Biosensor and SpectraWAVE.
Hypermed offers HyperViewâ„¢ and OxyVuâ„¢-1.
Hypermed operates through Hypermed Imaging, Inc..